v3.25.2
UNAUDITED INTERIM CONDENSED CONSOLIDATED STATEMENTS OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME/(LOSS) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
REVENUE        
License revenue $ 35,338 $ 90,846 $ 44,686 $ 103,027
Collaboration revenue 219,717 93,254 405,332 171,735
Other revenue 3 2,423 93 5,752
Total revenue 255,058 186,523 450,111 280,514
Cost of collaboration revenue (94,872) (45,355) (164,369) (94,456)
Cost of license and other revenue (3,119) (5,096) (4,966) (10,734)
Research and development expenses (98,302) (112,626) (200,226) (213,590)
Administrative expenses (32,594) (35,353) (64,057) (67,282)
Selling and distribution expenses (48,052) (30,063) (89,021) (54,286)
Loss on asset impairment 0 0 (970) 0
Finance costs (5,222) (5,484) (10,283) (10,959)
Finance income [1] 10,433 17,049 22,489 30,919
Other (expense)/income, net [1] (108,128) 12,435 (162,636) 62,116
Loss before tax (124,798) (17,970) (223,928) (77,758)
Income tax expense (582) (226) (2,368) (231)
Net loss $ (125,380) $ (18,196) $ (226,296) $ (77,989)
LOSS PER SHARE        
Basic (in dollars per share) $ (0.34) $ (0.05) $ (0.62) $ (0.21)
Diluted (in dollars per share) $ (0.34) $ (0.05) $ (0.62) $ (0.21)
Other comprehensive income/(loss)        
Exchange differences on translation of foreign operations $ 124,200 $ (10,535) $ 184,929 $ (58,528)
Other comprehensive income/(loss), net of tax 124,200 (10,535) 184,929 (58,528)
Total comprehensive loss $ (1,180) $ (28,731) $ (41,367) $ (136,517)
[1] Certain prior year amounts have been reclassified to present finance income as a separate line item and to combine other income/(expense), net for comparative purposes.